Market Cap $3,783,968,101,869
24h Volume $99,188,933,975
BTC Market Cap $1,930,229,011,090
BTC Dominance 51.0%

Cred Live Price Update & Market Capitalization

Cred LBA Rank #762

$0.00021464 16.92%

Market Overview

Cred current market price is $0.00021464 with a 24 hour trading volume of $163. The total available supply of Cred is 0 LBA. It has secured Rank 762 in the cryptocurrency market with a marketcap of $0. The LBA price is 16.92% down in the last 24 hours.

The volume-weighted average price of the Cred is $0.00023636 in the last 24 hours. Live prices from all markets and coin market Capitalization. Stay up to date with the latest price movements. Check our coin stats data and see when there is an opportunity to buy or sell at best price in the market.

Buy Cred (LBA)

Sell Cred (LBA)

Cred Rank

762

Cred Price

$0.00021464

VWAP (24h)

$0.00023636

Price Change (24h)

16.92%

Market Cap

Trading Volume (24H)

$163

Circulating Supply

0 LBA

Max Supply

(Not Available)

Cryptocurrency Cred Calculator

Want to convert more cryptocurrencies?

Use Crypto Calculator

Cred Historical Data Price Chart

Cred Markets Exchange Data

Compare live prices of Cred on top exchanges.

#	Exchange	Pair	Price	Volume (24h)	Volume (%)
	Gate	LBA/USDT	$0.00021435	$132	81.28%
	Gate	LBA/ETH	$0.00021588	$30	18.72%

Cryptocurrency Latest News & Updates

ETH/BTC pair hits YTD low as Bitcoin dominance surges

ETH/BTC hits its lowest level this year as Bitcoin soars to a new all-time high, fueling market dominance debates....

Crypto murder: Two more arrested in Montreal crypto influencer case

Two additional arrests have been made in the case of Kevin Mirshahi, a cryptocurrency influencer whose body was discovered in a Montreal park last month. Quebec provincial police announced that Darius Perry, 27, and Nackael Hickey, 25, face charges of…...

Nasdaq-listed antibiotics developer Acurx to put $1m in Bitcoin on balance sheet

Public biopharmaceutical company Acurx Pharmaceuticals said it plans to buy up to $1 million worth of Bitcoin to hold as a “treasury reserve asset.” Acurx Pharmaceuticals, a biopharmaceutical company developer new antibiotics for hard-to-treat bacterial infections, is set to purchase…...